You are here

EnteroMedics

Enteromedics CEO To Depart- Is This Good?

Seeking Alpha

Thu, 08/27/15 - 05:25 pm

Weight loss: 1st commercial implant of EnteroMedics' Maestro device

Mass Device

Thu, 05/21/15 - 10:16 am

Maestro implant

Weight loss pacemaker company Enteromedics gearing up for commercial launch

Mass Device

Mon, 02/23/15 - 11:18 am

Maestro implant

5 Obesity Stocks Investors Are Watching

Yahoo/Benzinga

Thu, 01/15/15 - 08:53 am

Arena Pharmaceuticals

FDA clears new obesity device

Seeking Alpha

Wed, 01/14/15 - 10:53 am

2nd Half Of 2014 Biotechnology Catalysts: Part 1

Seeking Alpha

Tue, 05/27/14 - 11:53 am

BioDelivery Sciences

Eagle Pharmaceuticals

Navidea Biopharmaceuticals

Trimel Pharmaceuticals

A Look At 3 Obesity Stocks

Seeking Alpha

Tue, 03/5/13 - 11:52 am

Arena Pharmaceuticals

EnteroMedics acknowledges mixed results for obesity device pivotal trial

FierceMedicalDevice

Thu, 02/7/13 - 09:19 pm

clinical trials

EnteroMedics: Fat Zapper or Pulsing Placebo?

TheStreet.com

Wed, 02/6/13 - 08:37 am

Arena Pharmaceuticals

The Obesity Epidemic: EnteroMedics' New Treatment Approach

Seeking Alpha

Tue, 01/29/13 - 11:09 am

Arena Pharmaceuticals

EnteroMedics Secures a $45 Million Committed Issuer Managed Equity Financing Facility With Terrapin Opportunity, L.P.

Thu, 10/4/12 - 10:51 pm

Weight loss: EnteroMedics gains on $75M stock offering

Wed, 08/15/12 - 09:45 pm

public offering

EnteroMedics Reports Second Quarter 2012 Financial Results

Wed, 08/8/12 - 12:02 am

EnteroMedics Announces First Commercial Implants of the Maestro(R) Rechargeable System

Tue, 06/5/12 - 10:29 pm

EnteroMedics Announces Completion of Patient Enrollment and Device Implantation in the ReCharge Pivotal Trial for Obesity

Wed, 12/28/11 - 04:55 pm

clinical trials

EnteroMedics Reports Third Quarter 2011 Financial Results

Thu, 10/20/11 - 10:56 pm

EnteroMedics Announces Closing of $14.5 Million Public Offering of Common Stock and Warrants

Wed, 09/28/11 - 08:44 pm

EnteroMedics Announces Proposed Public Offering of Common Stock and Warrants

Thu, 09/22/11 - 10:15 pm

EnteroMedics reports loss for the quarter

Thu, 07/21/11 - 12:53 pm

EnteroMedics Announces First Implant in ReCharge Pivotal Trial for Obesity

Wed, 05/18/11 - 06:24 pm

Pages